格隆汇4月29日｜辉瑞(PFE.US)涨超3%，报23.755美元。消息面上，辉瑞周二公布，在加大成本削减力度下，首季净利润同比跌约5%至29.7亿美元，经调整每股盈利92美仙，远高于市场预期的66美仙；营收同比跌8%至137.2亿美元，反映其抗病毒药物Paxlovid的收入减少。公司预计，通过两项成本削减措施，到2027年底将节省约77亿美元。公司维持对2025年全年财报的预期，预计销售额为610亿至640亿美元，惟补充该指引目前不包括与未来关税和贸易政策变化相关的任何潜在影响。

海量资讯、精准解读，尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.